Table 2.
Statin Use Details Among White Clinical Trials and Observational Study Participants (N=8824)
| Variable | No. of Patients | % |
|---|---|---|
| Type of statin used | ||
| Atorvastatin calcium | 675 | 7.6 |
| Fluvastatin sodium | 1036 | 11.7 |
| Lovastatin | 2354 | 26.7 |
| Pravastatin sodium | 1895 | 21.5 |
| Simvastatin | 2643 | 30 |
| ≥2 Statins | 221 | 2.5 |
| Statin potencya | ||
| Low (lovastatin, fluvastatin) | 3390 | 38.4 |
| Medium (pravastatin) | 1895 | 21.5 |
| High (simvastatin, atorvastatin) | 3318 | 37.6 |
| Statin categorya | ||
| Lipophilic (fluvastatin, lovastatin, simvastatin) | 6033 | 68.4 |
| Other (atorvastatin, pravastatin) | 2570 | 29.1 |
| Statin use duration, y | ||
| <1 | 2918 | 33.1 |
| 1 to <3 | 2966 | 33.6 |
| ≥3 | 2940 | 33.3 |
| <5 | 7345 | 83.2 |
| ≥5 | 1479 | 16.8 |
a
This category excludes participants who were receiving ≥2 statins.